Y
Yoram Bouhnik
Researcher at University of Paris
Publications - 93
Citations - 6333
Yoram Bouhnik is an academic researcher from University of Paris. The author has contributed to research in topics: Inflammatory bowel disease & Ulcerative colitis. The author has an hindex of 34, co-authored 93 publications receiving 5652 citations. Previous affiliations of Yoram Bouhnik include Paris Descartes University & Beaujon Hospital.
Papers
More filters
Journal ArticleDOI
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
Spl Travis,Eduard F. Stange,Marc Lémann,Tom Øresland,Yehuda Chowers,Alastair Forbes,G. D'Haens,G Kitis,Antoine Cortot,Cosimo Prantera,P. Marteau,J-F Colombel,Paolo Gionchetti,Yoram Bouhnik,Emmanuel Tiret,J Kroesen,M Starlinger,Neil Mortensen +17 more
TL;DR: This second section of the European Crohn’s and Colitis Organisation (ECCO) Consensus on the management of Crohn's disease concerns treatment of active disease, maintenance of medically induced remission, and surgery.
Journal ArticleDOI
Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines
Julián Panés,Yoram Bouhnik,Walter Reinisch,Jaap Stoker,Stuart A. Taylor,Daniel C. Baumgart,Silvio Danese,Steve Halligan,B. Marincek,Celso Matos,Laurent Peyrin-Biroulet,Jordi Rimola,Gerhard Rogler,G. Van Assche,Sandro Ardizzone,A. Ba-Ssalamah,M.A. Bali,Davide Bellini,Livia Biancone,Fabiana Castiglione,Robert Ehehalt,Roberto Grassi,Torsten Kucharzik,Francesca Maccioni,Giovanni Maconi,Fernando Magro,J. Martín-Comín,Giovanni Morana,Doug Pendse,Shaji Sebastian,Alberto Signore,D. Tolan,Jeroen A. W. Tielbeek,Dominik Weishaupt,B. Wiarda,Andrea Laghi +35 more
TL;DR: ECCO and ESGAR scientific societies jointly elaborated a consensus to establish standards for imaging in IBD using magnetic resonance imaging, computed tomography, ultrasonography, and including also other radiologic procedures such as conventional radiology or nuclear medicine examinations for different clinical situations.
Journal ArticleDOI
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
David Laharie,Arnaud Bourreille,Julien Branche,Matthieu Allez,Yoram Bouhnik,Jérôme Filippi,Frank Zerbib,Guillaume Savoye,Maria Nachury,Jacques Moreau,Jean-Charles Delchier,Jacques Cosnes,Elena Ricart,Olivier Dewit,Antonio López-Sanromán,Jean-Louis Dupas,Franck Carbonnel,Gilles Bommelaer,Benoit Coffin,Xavier Roblin,Gert Van Assche,Maria Esteve,Martti Färkkilä,Martti Färkkilä,Javier P. Gisbert,Philippe Marteau,Stéphane Nahon,Martine De Vos,Denis Franchimont,Jean Yves Mary,Jean-Frederic Colombel,Marc Lémann +31 more
TL;DR: Ciclosporin was not more effective than infliximab in patients with acute severe ulcerative colitis refractory to intravenous steroids and should be guided by physician and centre experience.
Journal ArticleDOI
Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine
Yoram Bouhnik,G. Scemama,R. Tai,Claude Matuchansky,Jean-Claude Rambaud,Marc Lémann,Robert Modigliani,Jean-Yves Mary +7 more
TL;DR: Taking into account the potential risks of long-term immunosuppressive therapy, the usefulness of maintaining azathioprine or 6-mercaptopurine in patients who have been in remission for more than 4 years is questionable.
Journal ArticleDOI
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial
P. Marteau,Marc Lémann,P. Seksik,D. Laharie,J.-F. Colombel,Yoram Bouhnik,Guillaume Cadiot,Soulé Jc,Arnaud Bourreille,Etienne Henry Metman,Eric Lerebours,F. Carbonnel,J.L. Dupas,Michel Veyrac,Benoit Coffin,J. Moreau,V. Abitbol,S. Blum-Sperisen,Jean-Yves Mary +18 more
TL;DR: The probiotic strain L johnsonii LA1 (4×109 cfu/day) did not have a sufficient effect, if any, to prevent endoscopic recurrence of Crohn’s disease.